Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy
Clinical trial NCT03804879 · COMPLETED
Trial details
- NCT number
- NCT03804879
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2021-05-03
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.